Cargando…
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris
Recombinant protein-based SARS-CoV-2 vaccines are needed to fill the vaccine equity gap. Because protein-subunit based vaccines are easier and cheaper to produce and do not require special storage/transportation conditions, they are suitable for low-/middle-income countries. Here, we report our vacc...
Ejemplares similares
-
Comparison and efficacy of two different sheep pox vaccines prepared from the Bakırköy strain against lumpy skin disease in cattle
por: Uzar, Serdar, et al.
Publicado: (2022) -
Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo
por: Kayabolen, Alisan, et al.
Publicado: (2022) -
Structural rearrangement of Neisseria meningitidis transferrin binding protein A (TbpA) prior to human transferrin protein (hTf) binding
por: DURAN, Gizem Nur, et al.
Publicado: (2021) -
The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors
por: Sonugür, F. Gizem, et al.
Publicado: (2019) -
Acromion-axillary nerve distance and its relation to the arm length in the prediction of the axillary nerve position: a clinical study
por: Yildirim, Cem, et al.
Publicado: (2022)